[Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].
Larsson
R
R
Avdelningen för klinisk farmakologi, vid Riksföreningen mot cancer, Uppsala.
Nygren
P
P
Bergh
J
J
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004351:Drug Resistance / Q000235:genetics*; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D010641:Phenotype; D011379:Prognosis; D013548:Sweden; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins
Experimentell farmakologisk tumörbehandling med klinisk potential.